Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$7.09 - $89.45 $85,895 - $1.08 Million
-12,115 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$80.85 - $128.49 $979,497 - $1.56 Million
12,115 New
12,115 $1.03 Million
Q1 2019

May 14, 2019

SELL
$6.43 - $9.44 $156,371 - $229,571
-24,319 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$6.11 - $10.43 $148,589 - $253,647
24,319 New
24,319 $173,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $417M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.